These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1636427)

  • 1. Repeated measurements of compound action potential: evaluation of the ototoxicity of otic drops.
    Morizono T; Tono T; Sano N
    Acta Otolaryngol Suppl; 1992; 493():77-80. PubMed ID: 1636427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon.
    Wright CG; Meyerhoff WL; Halama AR
    Am J Otol; 1987 Nov; 8(6):495-9. PubMed ID: 2829633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochleotoxicity of otic drops in the chinchilla: comparative study of Bestron and Cortisporin.
    Ikeda K; Morizono T; Juhn SK
    Am J Otol; 1991 Nov; 12(6):429-34. PubMed ID: 1805633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of ototopical drugs: animal modeling.
    Morizono T
    Ann Otol Rhinol Laryngol Suppl; 1990 Jun; 148():42-5. PubMed ID: 2112363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tympanostomy tubes and otic drops.
    Meyerhoff WL; Morizono T; Wright CG; Shaddock LC; Shea DA; Sikora MA
    Laryngoscope; 1983 Aug; 93(8):1022-7. PubMed ID: 6308368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Round window membrane permeability during experimental purulent otitis media: altered Cortisporin ototoxicity.
    Ikeda K; Morizono T
    Ann Otol Rhinol Laryngol Suppl; 1990 Jun; 148():46-8. PubMed ID: 2161637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxicity of an ototopical preparation in a primate.
    Wright CG; Halama AR; Meyerhoff WL
    Am J Otol; 1987 Jan; 8(1):56-60. PubMed ID: 3031988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ototoxicity of an ototopic preparation--experimental results and clinical facts.
    Halama AR; Wright CG; Meyerhoff WL
    Acta Otorhinolaryngol Belg; 1991; 45(3):279-82. PubMed ID: 1950546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory effects of otic drops on the middle ear.
    Anderson RG; Wright CG; Meyerhoff WL
    Int J Pediatr Otorhinolaryngol; 1984 May; 7(2):91-5. PubMed ID: 6086545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin and cisplatin ototoxicity in guinea pigs.
    Taudy M; Syka J; Popelár J; Ulehlová L
    Audiology; 1992; 31(5):293-9. PubMed ID: 1449432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of ofloxacin (OFLX) and fosfomycin sodium (FOM) ear drops.
    Yamano T; Morizono T; Shiraishi K; Miyagi M; Imamura A; Kato T
    Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):979-83. PubMed ID: 17434212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ototoxicity from drugs applied topically to the middle ear space.
    Brummett RE; Harris RF; Lindgren JA
    Laryngoscope; 1976 Aug; 86(8):1177-87. PubMed ID: 181649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ototoxicity of aluminum acetate/benzethonium chloride otic solution in the chinchilla animal model.
    Pitaro J; Mood ZA; Daniel SJ
    Laryngoscope; 2013 Oct; 123(10):2521-5. PubMed ID: 23918745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of ototopical antibiotics.
    Welling DB; Forrest LA; Goll F
    Laryngoscope; 1995 May; 105(5 Pt 1):472-4. PubMed ID: 7760659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of round window membrane application of salicylate and indomethacin on hearing and levels of arachidonic acid metabolites in perilymph.
    Jung TT; Miller SK; Rozehnal S; Woo HY; Park YM; Baer W
    Acta Otolaryngol Suppl; 1992; 493():81-7. PubMed ID: 1636428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ototoxicity of otic drops applied to the middle ear in the chinchilla.
    Wright CG; Meyerhoff WL
    Am J Otolaryngol; 1984; 5(3):166-76. PubMed ID: 6331211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cortisporin otic suspension on cochlear function and efferent activity in the guinea pig.
    Perry BP; Smith DW
    Laryngoscope; 1996 Dec; 106(12 Pt 1):1557-61. PubMed ID: 8948623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss.
    Kopke RD; Coleman JK; Liu J; Campbell KC; Riffenburgh RH
    Laryngoscope; 2002 Sep; 112(9):1515-32. PubMed ID: 12352659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of mitomycin C to the middle ear is ototoxic in the gerbil.
    Moody MW; Lang H; Spiess AC; Smythe N; Lambert PR; Schmiedt RA
    Otol Neurotol; 2006 Dec; 27(8):1186-92. PubMed ID: 16788424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.